Document Detail


Chronic viral hepatitis.
MedLine Citation:
PMID:  11070570     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Both hepatitis B and hepatitis C are spread parenterally. Chronic hepatitis C is fast becoming the leading indication for liver transplantation. Most infected patients go on to develop chronic hepatitis, with approximately 20% developing liver cirrhosis or hepatocellular carcinoma after 20 years. Standard treatment now is with a combination of alpha-interferon and ribavirin, which is successful in up to 40% of patients. A vaccine is still a remote possibility and prevention remains all-important. Despite having a successful vaccine, chronic hepatitis B remains an important cause of liver cirrhosis and hepatocellular carcinoma. Treatments for active hepatitis include alpha-interferon and the newer nucleoside analogues such as lamivudine and adefovir. In patients undergoing liver transplantation, recurrence of hepatitis B in the graft can be reduced with a combination of hepatitis B immunoglobulin and these nucleoside analogues.
Authors:
G Alexander; K Walsh
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  International journal of clinical practice     Volume:  54     ISSN:  1368-5031     ISO Abbreviation:  Int. J. Clin. Pract.     Publication Date:  2000 Sep 
Date Detail:
Created Date:  2000-11-20     Completed Date:  2000-11-20     Revised Date:  2007-02-14    
Medline Journal Info:
Nlm Unique ID:  9712381     Medline TA:  Int J Clin Pract     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  450-6     Citation Subset:  IM    
Affiliation:
Department of Medicine, Addenbrooke's Hospital, Cambridge, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antiviral Agents / therapeutic use
Enzyme-Linked Immunosorbent Assay
Hepatitis B, Chronic* / diagnosis,  therapy,  virology
Hepatitis C, Chronic* / diagnosis,  therapy,  virology
Hepatitis D, Chronic / diagnosis,  therapy,  virology
Humans
Interferon-alpha / therapeutic use
Liver Transplantation / methods
Polymerase Chain Reaction / methods
Chemical
Reg. No./Substance:
0/Antiviral Agents; 0/Interferon-alpha

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of statins in acute coronary syndromes: managing the unmet need.
Next Document:  Diagnoses in discharge communications: how far are they reliable?